Find news about people
Find news about organizations
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions


Change Feed
Investments in Pharmaceuticals
... using the Wechsler Memory Scale. Neflamapimod (previously VX-745) was discovered by Vertex Pharmaceuticals Inc. and licensed by EIP Pharma in 2014. Prior to licensing, Vertex ...
... CANADIAN DAILY STOCK REPORT RepliCel Life Sciences Inc. (TSXV:RP), Canada's 47th largest Biotechnology company by market cap, has lifted ...
... PhoreMost, the UK-based biopharmaceutical company dedicated to drugging 'undruggable' disease targets, today announced ...
... Portsmouth, NH (USA) and Basel (CH) - Lonza Pharma Biotech announced today the investment in a new phase of development ...
... CAMBRIDGE - Moderna Therapeutics and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced ...
... May 2018 20:30 EDT ORIGINAL ANNOUNCEMENT [Text] TORONTO, May 08, 2018 -- Emblem Corp. (TSXV:EMC) (EMC.WT) ("Emblem" or the "Corporation") announces that it has agreed ...
... Good afternoon, readers! This is Sy. Embattled drug maker Valeant finally got a bit of good news as the Food and Drug ...
Subscribe now for full coverage on Investments in Pharmaceuticals
Start My Free Trial